PHF1 and Alzheimer disease: We first characterized the ADNC and reactive gliosis of CTRL and AD donors via quantitative immunohistochemistry for Aβ, pTau (PHF1, pTauSer396/404), reactive astrocytes (GFAP), and reactive microglia (CD68), and also measured the cortical thickness in the temporal association neocortex.